The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia

Obesity

Volumn 22, Issue 3, 2014, Pages 652-662

  Straznicky, Nora E ^a   Lambert, Elisabeth A ^a,b,c   Grima, Mariee T ^a   Eikelis, Nina ^a   Richards, Katrina ^a   Nestel, Paul J ^a   Dawood, Tye ^a   Masuo, Kazuko ^a   Sari, Carolina I ^a   Dixon, John B ^a,b   Esler, Murray D ^a,b   Paul, Eldho ^b   Schlaich, Markus P ^a,b   Lambert, Gavin W ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; DOPA; NORADRENALIN;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FOOD COMPOSITION; HUMAN; HYPERINSULINEMIA; LOW CALORY DIET; MALE; METABOLIC SYNDROME X; NEUROCHEMISTRY; NEUROMODULATION; OBESITY; STEADY STATE; SYMPATHETIC FUNCTION; THERAPY EFFECT; TREATMENT DURATION; TURNOVER TIME; WEIGHT REDUCTION;

BODY MASS INDEX; DIET, REDUCING; DIHYDROXYPHENYLALANINE; DOWN-REGULATION; ENERGY METABOLISM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERINSULINISM; MALE; METABOLIC SYNDROME X; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; NOREPINEPHRINE; OBESITY; SYMPATHETIC NERVOUS SYSTEM; WEIGHT LOSS;

EID: 84895797900     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20614     Document Type: Article

References (40)

1. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
2. Mozumdar A, Liguori G,. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES I 1999-2006. Diabetes Care 2011; 34: 216-219.
3. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912.
4. Grassi G, Dell'Oro R, Quatri-Trevano F, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005; 48: 1359-1365.
5. Alvarez GE, Beske SD, Ballard TP, Davy KP,. Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533-2536.
6. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL,. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992; 19: 621-627.
7. Lambert E, Straznicky N, Sari CI, et al. Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 2013; 26: 250-256.
8. Straznicky NE, Grima MT, Sari CI, et al. Neuroadrenergic dysfunction along the diabetic continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012; 61: 2506-2516.
9. Tentolouris N, Argyrakopoulou G, Katsilambros N,. Perturbed autonomic nervous system function in metabolic syndrome. Neuromol Med 2008; 10: 169-178.
10. Lambert E, Sari C, Dawood T, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010; 56: 351-358.
11. Masuo K, Mikami H, Ogihara T, Tuck ML,. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997; 10: 77-83.
12. Zoccali C, Mallamaci F, Parlongo S, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359.
13. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler DM, Nestel PJ,. Effects of dietary weight loss on sympathetic activity and cardiovascular risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 5998-6005.
14. Straznicky NE, Lambert EA, Nestel PJ, et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 2010; 59: 71-79.
15. Eisenhofer G, Goldstein DS, Kopin IJ,. Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. Clin Sci 1989; 76: 171-182.
16. Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM,. Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res 1993; 602: 161-164.
17. Robertson SD, Matthies HJG, Owens WA, et al. Insulin reveals Akt signalling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci 2010; 30: 11305-11316.
18. Schlaich MP, Lambert E, Kaye DM, et al. Sympathtetic augmentation in hypertension. Role of nerve firing, norepinephrine reuptake and angiotensin neuromodulation. Hypertension 2004; 43: 169-175.
19. Anan F, Masaki T, Yonemochi H, et al. Abdominal visceral fat accumulation is associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 2007; 34: 1189-1197.
20. Thibault L, Roberge AG,. Comparative effects of carbohydrate restriction versus starvation on biochemical parameters related to neurotransmitters in rat. J Am Coll Nutr 1989; 8: 35-46.
21. Giordano A, Frontini A, Murano I, et al. Regional-dependent increase of sympathetic innervation in rat white adipose tissue during prolonged fasting. J Histochem Cytochem 2005; 53: 679-687.
22. Eisenhofer G, Meredith IT, Ferrier C, et al. Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. J Lab Clin Med 1991; 117: 266-273.
23. Landsberg L, Young JB,. Fasting, feeding and regulation of the sympathteic nervous system. N Engl J Med 1978; 298: 1295-1301.
24. O'Dea K, Esler M, Leonard P., Stockigt JR, Nestel P,. Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism 1982; 31: 896-899.
25. Katzeff HL, O'Connell M, Horton ES, Danforth E, Young JB, Landsberg L,. Metabolic studies of human obesity during overnutrition and undernutrition: thermogenic and hormonal responses to norepinephrine. Metabolism 1986; 35: 166-175.
26. Habecker BA, Willison BD, Shi X, Woodward WR,. Chronic depolarization stimulates norepinephrine transporter expression via catecholamines. J Neurochem 2006; 97: 1044-1051.
27. Parrish DC, Gritman K, Van Winkle DM, Woodward WR, Bader M, Habecker BA,. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am J Physiol Heart Circ Physiol 2008; 294: H99-H106.
28. Lee CM, Javitch JA, Snyder SH,. Recognition sites for norepinephrine uptake: regulation by neurotransmitter. Science 1983; 220: 626-629.
29. Kiyono Y, Kajiyama S, Fujiwara H, Kanegawa N, Saji H,. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic sympathetic nerves: implications for heterogeneous accumulation of MIBG. Eur J Nucl Med Mol Imaging 2005; 32: 438-442.
30. Thackeray JT, Radziuk J, Harper ME, et al. Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia. Cardiovasc Diabetol 2011; 10: 75.
31. Esler M, Jackman G, Leonard P, Skews H, Bobik A, Korner P,. Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clin Pharmacol Ther 1981; 29: 12-20.
32. Baily RG, Leuenberger U, Leaman G, Silber D, Sinoway LI,. Norepinephrine kinetics and cardiac output during nonhypotensive lower body negative pressure. Am J Physiol 1991; 260: H1708-H1712.
33. Ziegler MG, Chernow B, Woodson LC, Coyle J, Cruess D, Lake CR,. The effect of propranolol on catecholamine clearance. Clin Pharmacol Ther 1986; 40: 116-119.
34. Andersson OK, Fagerberg B, Hedner T,. Importance of dietary salt in the hemodynamic adjustment to weight reduction in obese hypertensive men. Hypertension 1984; 6: 814-819.
35. Blumenthal JA, Sherwood A, Gullette ECD, et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension. Effects on cardiovascular, metabolic, and hemodynamic functioning. Arch Intern Med 2000; 160: 1947-1958.
36. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L,. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30: 219-225.
37. Berne C, Fagius J, Nikiasson F,. Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings. J Clin Invest 1989; 84: 1403-1409.
38. Ward KR, Bardgett JF, Wolfgang L, Stocker SD,. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 2011; 57: 435-441.
39. Rahmouni K, Morgan DA, Morgan GM, et al. 2004 Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest 2004; 114: 652-658.
40. Kaufman LN, Young JB, Landsberg L,. Differential catecholamine responses to dietary intake: effects of macronutrients on dopamine and epinephrine excretion in the rat. Metabolism 1989; 38: 91-99.